跳至主要内容
临床试验/NCT02113774
NCT02113774Unknown4 期

The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients

Rabin Medical Center0 个研究点开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
4 期
主要终点
development of symptomatic urinary tract infection

研究概览

简要总结

The investigators hypothesize that antibiotic therapy for asymptomatic bacteriuria in renal transplant patients does not have impact on the development of symptomatic urinary tract infection (UTI) or progression of renal impairment in patients during the first year after transplantation.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are ≥1 month and ≤ 12 months after renal transplantation.
  • Positive urine culture defined as ≥ 105 colony forming units (CFU) per milliliter of a known single pathogen.

排除标准

  • Any one of the following signs and symptoms: fever, abdominal pain, dysuria, frequency, urgency, flank pain, costovertebral-angel tenderness or tenderness over the transplanted kidney
  • Active infections in another site
  • Leucocytosis (WBC >18.000K/micl) or leucopenia (WBC < 3.000 K/micl)
  • Elevation of serum creatinine of more than 15% of its baseline level
  • Obstructive or other urological complications following transplantation as known foreign device (stent/double-J-Cath, any catheter) in the urinary tract system, known obstruction of the transplanted kidney, indwelling or intermittent catheterization
  • Pregnant or lactating women.
  • Candidates to invasive urologic procedures.
  • Inability to return for regular follow up.
  • Previous enrollment in this study.
  • Patients who incapable of giving informed consent.

结局指标

主要结局

development of symptomatic urinary tract infection

时间窗: 30 days

次要结局

  • 25% reduction in estimated glomerular filtration rate (eGFR)(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ruth Rahamimov

head of transplant investigator service

Rabin Medical Center

相似试验